Startup launches new platform to accelerate AI in healthcare
A startup that specialises in healthcare analytics and AI has launched a new platform that aims to help healthcare providers accelerate their digital journeys to make a return on their investment (ROI).
KenSci's new AI platform, built on Microsoft Azure, aims to helps healthcare organisations accelerate their data transformation, enabling AI and analytics workloads at scale.
The startup, which is headquartered in Seattle, has launched their re-imagined platform with the latest predictive analytics technology, to enable health organisations to develop business intelligence (BI) and AI-based workloads in an easy, agile way.
The platform has been built specifically for the healthcare sector, designed to provide AI-based insights on operational and clinical workflows. Users can customise it to suit their needs or use the solutions already built into the software.
Samir Manjure, KenSci chief executive officer, explained his vision for the new product: "Healthcare organisations have access to a treasure trove of data which can be maximized to gain insights and improve quality of care and the patient experience.
"The bottleneck in the AI journey originates from the time it takes to transform and shape data into a format that allows for intelligent insights to be extracted. The KenSci AI Platform for Digital Health aims to bridge this gap using a modern AI-ready data architecture that we truly believe will be a game changer in making the healthcare industry AI-ready."
The platform integrates Microsoft Power BI data visualization tools, so that healthcare teams can use auto-generated key performance indicators, metrics and pre-built integrations directly into Microsoft Power Apps, Microsoft Teams and EMRs to streamline adoption.
"Through collaboration with Microsoft and using their healthcare technology expertise, KenSci is helping healthcare organizations simplify their data movement to the cloud, accelerating use of AI in improving operational and care management outcomes" Heather Cartwright, General Manager at Microsoft Health said.
"KenSci's AI platform for digital health helps health teams build data-rich use-cases and innovate in a secure data pipeline within their own Azure environments."
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”